Margaret Olutayo Alese
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Margaret Olutayo Alese has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Jagidesa Moodley
Women's Health and HIV Research Group, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Private Bag 7, Durban, 4013, South Africa
4 shared publicationsOluwole Ojo Alese
Ekiti State Univ, Coll Med, Dept Physiol, Ado Ekiti, Nigeria
3 shared publicationsThajasvarie Naicker
Optics and Imaging Centre, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Private Bag 7, Durban, 4013, South Africa
3 shared publicationsO.O. Alese
Department of Physiology, College of Medicine, Ekiti State University, Ado-Ekiti, Nigeria
2 shared publicationsOlawande Damilola Bamisi
Ekiti State Univ, Coll Med, Dept Anat, PMB 5363, Ado Ekiti, Nigeria
2 shared publications- Sunday Adelaja Ajayi
Obafemi Awolowo University, Ile-Ife, Nigeria
2 shared publications
Latest Publications
- Open Access
- 1 August 2025
- Published by InkVista Publishing House in Journal of Research in Applied and Basic Medical Sciences
- Vol. 11 (3) , 235-243
Toxicological and Histopathological Screening of Some Medicinal Plant Extracts Used as Protectants Against Insect Infestation
Background The use of medicinal plants as alternatives to synthetic chemicals in combating stored product pests is gaining more attention. Plants are known for their medicinal and insecticidal properties; however, the safety of these plants for humans needs further investigation. The toxicities of ethanol extracts of Uvaria chamae root bark, ...
- 1 August 2025
- Published by InkVista Publishing House in Journal of Research in Applied and Basic Medical Sciences
- Vol. 11 (3) , 235-243
Open AccessToxicological and Histopathological Screening of Some Medicinal Plant Extracts Used as Protectants Against Insect Infestation
Background The use of medicinal plants as alternatives to synthetic chemicals in combating stored product pests is gaining more attention. Plants are known for their medicinal and insecticidal properties; however, the safety of these plants for humans needs further investigation. The toxicities of ethanol extracts of Uvaria chamae root bark, ...
- 8 December 2022
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 22 (1) , 455-468
Anacardium occidentale leaves extract and riboceine mitigate hyperglycemia through anti-oxidative effects and modulation of some selected genes associated with diabetes
Background Diabetes mellitus (DM) is one of the leading causes of death globally and complications of DM have become a major health concern. Anacardium occidentale is a plant widely recognized for its hypoglycemic properties and traditionally used in developing nations as remedy for DM treatment. Riboceine is a supplement that enhances production of glutathione and known for its vital role in supporting cellular function. This study was designed to evaluate the antidiabetic and antioxidant potential of riboceine and ethanolic extract of A. occidentale leaves in streptozotocin (STZ)-induced diabetic rats. Method Twenty-nine adult male Wistar rats were induced with DM intraperitoneally using a single dose of STZ (70 mg/kg). The STZ-induced rats were divided into groups and administered the same dose (100 mg/kg) of A. occidentale leaves extract and riboceine via gastric gavage at the dose (100 mg/kg) for seventeen days while metformin (40 mg/kg) was used as positive control. Fasting blood glucose and weight of the model rats were examined periodically. Activities of total protein, creatinine, urea, antioxidants (SOD, GSH and GPX), and level of serum insulin were determined. Expression of diabetes related genes including pancreas (Insulin, pdx-1, P16NK4A, and Mki-67), Liver (FAS, ACC, and GFAT) and KIM-1 genes were also determined. Results Data showed that treatment of STZ-induced diabetic rats with A. occidentale and riboceine at the same dose significantly (p < 0.05) ameliorated hyperglycemic effects by improving hepatic and renal functions and antioxidants, preventing hepatic fat accumulation by downregulation of ACC, FAS and GFAT expression, improving β-cell functions through up-regulation of pancreatic insulin, P16NK4A, Mki-67 and pdx-1 expression. Induction of diabetes upregulated mRNA expression of KIM-1, which was ameliorated after treatment of the rats with A. occidentale and riboceine. Conclusion The results obtained in this study demonstrate significant antidiabetic properties of ethanolic extract of A. occidentale and riboceine.
- 8 December 2022
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 22 (1) , 455-468
Anacardium occidentale leaves extract and riboceine mitigate hyperglycemia through anti-oxidative effects and modulation of some selected genes associated with diabetes
Background Diabetes mellitus (DM) is one of the leading causes of death globally and complications of DM have become a major health concern. Anacardium occidentale is a plant widely recognized for its hypoglycemic properties and traditionally used in developing nations as remedy for DM treatment. Riboceine is a supplement that enhances production of glutathione and known for its vital role in supporting cellular function. This study was designed to evaluate the antidiabetic and antioxidant potential of riboceine and ethanolic extract of A. occidentale leaves in streptozotocin (STZ)-induced diabetic rats. Method Twenty-nine adult male Wistar rats were induced with DM intraperitoneally using a single dose of STZ (70 mg/kg). The STZ-induced rats were divided into groups and administered the same dose (100 mg/kg) of A. occidentale leaves extract and riboceine via gastric gavage at the dose (100 mg/kg) for seventeen days while metformin (40 mg/kg) was used as positive control. Fasting blood glucose and weight of the model rats were examined periodically. Activities of total protein, creatinine, urea, antioxidants (SOD, GSH and GPX), and level of serum insulin were determined. Expression of diabetes related genes including pancreas (Insulin, pdx-1, P16NK4A, and Mki-67), Liver (FAS, ACC, and GFAT) and KIM-1 genes were also determined. Results Data showed that treatment of STZ-induced diabetic rats with A. occidentale and riboceine at the same dose significantly (p < 0.05) ameliorated hyperglycemic effects by improving hepatic and renal functions and antioxidants, preventing hepatic fat accumulation by downregulation of ACC, FAS and GFAT expression, improving β-cell functions through up-regulation of pancreatic insulin, P16NK4A, Mki-67 and pdx-1 expression. Induction of diabetes upregulated mRNA expression of KIM-1, which was ameliorated after treatment of the rats with A. occidentale and riboceine. Conclusion The results obtained in this study demonstrate significant antidiabetic properties of ethanolic extract of A. occidentale and riboceine.
- 1 January 2021
- Vol. 14 (10) , 1048-1055
Progesterone modulates cadmium-induced oxidative stress and inflammation in hepatic tissues of Wistar rats
In recent times, there has been an increased risk of human exposure to cadmium especially in developing countries. We studied the role of progesterone as an anti-inflammatory and antioxidant agent in cadmium induced toxicity. Cadmium toxicity was induced with cadmium chloride (30 mg/kg) per oral while the control group was given distilled water. The Cd group was given CdCl2 only, P-4 group; progesterone only (10 mg/kg intraperitoneally) and Cd+P-4 group; CdCl2 and progesterone. All treatments lasted for 21 days. Following sacrifice, liver function tests and antioxidant status were assessed using standard kits; TNF alpha was immunolocalized across the study groups and the staining intensity measured using Image J software. Cadmium administration induced oxidative stress by a significant elevation in MDA and GC6P levels and a significant reduction in SOD, CAT, and GSH. These were attenuated by progesterone administration. While cadmium exposure caused an increase in serum ALT, AST, and ALP activities, progesterone significantly alleviated these effects. Inflammation shown by significant immunoreactivity in the TNF alpha positive cells in the liver in the cadmium group was reversed by progesterone. We conclude that cadmium toxicity induces oxidative stress that was attenuated by progesterone.
- 1 January 2021
- Vol. 14 (10) , 1048-1055
Progesterone modulates cadmium-induced oxidative stress and inflammation in hepatic tissues of Wistar rats
In recent times, there has been an increased risk of human exposure to cadmium especially in developing countries. We studied the role of progesterone as an anti-inflammatory and antioxidant agent in cadmium induced toxicity. Cadmium toxicity was induced with cadmium chloride (30 mg/kg) per oral while the control group was given distilled water. The Cd group was given CdCl2 only, P-4 group; progesterone only (10 mg/kg intraperitoneally) and Cd+P-4 group; CdCl2 and progesterone. All treatments lasted for 21 days. Following sacrifice, liver function tests and antioxidant status were assessed using standard kits; TNF alpha was immunolocalized across the study groups and the staining intensity measured using Image J software. Cadmium administration induced oxidative stress by a significant elevation in MDA and GC6P levels and a significant reduction in SOD, CAT, and GSH. These were attenuated by progesterone administration. While cadmium exposure caused an increase in serum ALT, AST, and ALP activities, progesterone significantly alleviated these effects. Inflammation shown by significant immunoreactivity in the TNF alpha positive cells in the liver in the cadmium group was reversed by progesterone. We conclude that cadmium toxicity induces oxidative stress that was attenuated by progesterone.
- 1 October 2020
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 48, 151604
Effects of various fixatives and temperature on the quality of glycogen demonstration in the brain and liver tissues
- 1 October 2020
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 48, 151604
Effects of various fixatives and temperature on the quality of glycogen demonstration in the brain and liver tissues
- 1 March 2020
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 246, 138-144
The role of Galectin-1 in HIV associated preeclampsia
- 1 March 2020
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 246, 138-144
The role of Galectin-1 in HIV associated preeclampsia
- 6 November 2019
- Published by Bioscientifica in Endocrine Abstracts
Molecular interactions of cashew leaf (Anacardium occidentale) derived compounds with anti-diabetic targets: in silico and in vivo studies
Anacardium occidentale (cashew tree) belongs to the Anacardiaceae family and has been well used in folklore medicine for the treatment of various ailments such as gastrointestinal disorders, hypertension and diabetes. Literature is replete with reported anti-diabetic actions of cashew leaf. The molecular mechanism of the hypoglycemic activity of A. occidentale was investigated in this study. Insulin, Glucagon like peptide-1 (GLP-1), dipeptidyl peptidase-4 (DPP-4) and marker of proliferation KI67 (MKI67) gene modulation by A. occidentale was investigated in vivo by RT-PCR and possible compounds responsible for anti-diabetic action predicted through in silico approach. Phytochemicals previously characterized from A. occidentale through GC−MS analysis were docked into glutamine fructose-6-phosphate amidotransferase (GFAT), glucagon like peptide-1 receptor (GLP-1r), dipeptidyl peptidase (DPP-4) using Autodock Vina. In silico findings suggest alphacadinol (ligand for DDP-4 and GFAT) and betacaryophylene (ligand for GLP-1r) as the major anti-diabetic compounds in cashew leaf. In vivo study showed increase in GLP-1, insulin and MKI-67 expression in A. occidentale-treated rats compared to the controls. This study indicates that the underlying molecular mechanisms of the actions of these compounds is through activation of insulin and GLP-1 receptor. This work confirmed the use of this plant in diabetes management and the probable bioactive components eliciting anti-diabetic effects are alphacadinol (a sesquiterpenoid) and betacaryphylene (a sesquiterpene) and both belong to the class of terpenes.
- 6 November 2019
- Published by Bioscientifica in Endocrine Abstracts
Molecular interactions of cashew leaf (Anacardium occidentale) derived compounds with anti-diabetic targets: in silico and in vivo studies
Anacardium occidentale (cashew tree) belongs to the Anacardiaceae family and has been well used in folklore medicine for the treatment of various ailments such as gastrointestinal disorders, hypertension and diabetes. Literature is replete with reported anti-diabetic actions of cashew leaf. The molecular mechanism of the hypoglycemic activity of A. occidentale was investigated in this study. Insulin, Glucagon like peptide-1 (GLP-1), dipeptidyl peptidase-4 (DPP-4) and marker of proliferation KI67 (MKI67) gene modulation by A. occidentale was investigated in vivo by RT-PCR and possible compounds responsible for anti-diabetic action predicted through in silico approach. Phytochemicals previously characterized from A. occidentale through GC−MS analysis were docked into glutamine fructose-6-phosphate amidotransferase (GFAT), glucagon like peptide-1 receptor (GLP-1r), dipeptidyl peptidase (DPP-4) using Autodock Vina. In silico findings suggest alphacadinol (ligand for DDP-4 and GFAT) and betacaryophylene (ligand for GLP-1r) as the major anti-diabetic compounds in cashew leaf. In vivo study showed increase in GLP-1, insulin and MKI-67 expression in A. occidentale-treated rats compared to the controls. This study indicates that the underlying molecular mechanisms of the actions of these compounds is through activation of insulin and GLP-1 receptor. This work confirmed the use of this plant in diabetes management and the probable bioactive components eliciting anti-diabetic effects are alphacadinol (a sesquiterpenoid) and betacaryphylene (a sesquiterpene) and both belong to the class of terpenes.
- 1 July 2019
- Published by Elsevier in Pregnancy Hypertension
- Vol. 17, 15-19
Liver enzyme patterns in maternal deaths due to eclampsia: A South African cohort
- 1 July 2019
- Published by Elsevier in Pregnancy Hypertension
- Vol. 17, 15-19
Liver enzyme patterns in maternal deaths due to eclampsia: A South African cohort
- 1 March 2019
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 39 (5) , 612-618
Signalling of ERK1/2, P38MAPK and P90RSK in HIV-associated pre-eclampsia
Due to their significance in trophoblast differentiation and survival, we evaluated the expression of the cell signalling molecules; Extracellular signal–regulated kinase 1/2 (ERK1/2), Mitogen Activated Protein Kinase 38 (MAPK38) and p90 ribosomal protein S6 kinase (p90 RSK) in buffy coat samples. Eighty pregnant women attending a large hospital in Durban, South Africa were assigned into normotensive and pre-eclamptic groups and further stratified by their HIV status. The degree of phosphorylation of the analytes was determined using the Bio-Plex ProTM Cell Signalling Immunoassay. There was a significantly lower protein concentration of the analytes in the pre-eclamptic versus the normotensive patients, irrespective of HIV status (p < .0001). Also, there was no significant difference in expression of ERK1/2 (p = .4369), p38MAPK (p = .4720) and p90 RSK (p = .0188), according to HIV status. This study demonstrates a down-regulation of ERK1/2, p38MAPK and p90RSK prosurvival markers in pre-eclampsia. This implicates the involvement of the MAPK pathway in the pathogenesis of preeclampsia. Activation of these pathways may prove useful in increasing the body of evidence on prevention of placenta dysfunction and apoptosis.
- 1 March 2019
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 39 (5) , 612-618
Signalling of ERK1/2, P38MAPK and P90RSK in HIV-associated pre-eclampsia
Due to their significance in trophoblast differentiation and survival, we evaluated the expression of the cell signalling molecules; Extracellular signal–regulated kinase 1/2 (ERK1/2), Mitogen Activated Protein Kinase 38 (MAPK38) and p90 ribosomal protein S6 kinase (p90 RSK) in buffy coat samples. Eighty pregnant women attending a large hospital in Durban, South Africa were assigned into normotensive and pre-eclamptic groups and further stratified by their HIV status. The degree of phosphorylation of the analytes was determined using the Bio-Plex ProTM Cell Signalling Immunoassay. There was a significantly lower protein concentration of the analytes in the pre-eclamptic versus the normotensive patients, irrespective of HIV status (p < .0001). Also, there was no significant difference in expression of ERK1/2 (p = .4369), p38MAPK (p = .4720) and p90 RSK (p = .0188), according to HIV status. This study demonstrates a down-regulation of ERK1/2, p38MAPK and p90RSK prosurvival markers in pre-eclampsia. This implicates the involvement of the MAPK pathway in the pathogenesis of preeclampsia. Activation of these pathways may prove useful in increasing the body of evidence on prevention of placenta dysfunction and apoptosis.
- 2 January 2019
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 34 (1) , 117-123
Preeclampsia and HELLP syndrome, the role of the liver
Preeclampsia is a multisystemic disorder which accounts for the high prevalence of maternal and perinatal morbidity and mortality, especially in middle and low-income countries. Currently, the primary intervention is the urgent delivery of the fetus, hence it would be advantageous to identify those who are likely to develop preeclampsia and the maternal and fetal outcomes. However, an array of risk factors makes these challenging. This review explores the potentials of liver biomarkers in predicting the occurrence and outcome of preeclampsia, which could be beneficial in reducing the burden of the disease. Liver dysfunction in preeclampsia results in a severe condition, hence liver function tests are specific predictors of outcome.
- 2 January 2019
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 34 (1) , 117-123
Preeclampsia and HELLP syndrome, the role of the liver
Preeclampsia is a multisystemic disorder which accounts for the high prevalence of maternal and perinatal morbidity and mortality, especially in middle and low-income countries. Currently, the primary intervention is the urgent delivery of the fetus, hence it would be advantageous to identify those who are likely to develop preeclampsia and the maternal and fetal outcomes. However, an array of risk factors makes these challenging. This review explores the potentials of liver biomarkers in predicting the occurrence and outcome of preeclampsia, which could be beneficial in reducing the burden of the disease. Liver dysfunction in preeclampsia results in a severe condition, hence liver function tests are specific predictors of outcome.
- 17 July 2018
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 50, 276-282
Cadmium induced damage in Wistar rats, ameliorative potentials of progesterone
- 17 July 2018
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 50, 276-282
Cadmium induced damage in Wistar rats, ameliorative potentials of progesterone